| scholarly article | Q13442814 |
| P50 | author | Baek Gyu Jun | Q59692250 |
| P2093 | author name string | Boo Sung Kim | |
| Eui Ju Park | |||
| Hong Soo Kim | |||
| Jae Young Jang | |||
| Sae Hwan Lee | |||
| Sang Gyune Kim | |||
| Soung Won Jeong | |||
| Woong Cheul Lee | |||
| Young Seok Kim | |||
| Young Don Kim | |||
| Young Sin Cho | |||
| Gab Jin Cheon | |||
| Yun Nah Lee | |||
| P2860 | cites work | Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin | Q45363470 |
| [Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection]. | Q50567373 | ||
| Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. | Q50571579 | ||
| Hepatitis C and hepatocellular carcinoma | Q73717368 | ||
| A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients | Q27487985 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Clinical practice. Chronic hepatitis C infection | Q28241445 | ||
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus | Q28279955 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The global burden of hepatitis C | Q29620138 | ||
| Thrombocytopenia in chronic hepatitis C. | Q33393432 | ||
| Causes of thrombocytopenia in chronic hepatitis C viral infection | Q33399654 | ||
| Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008 | Q33400231 | ||
| Platelet count and sustained virological response in hepatitis C treatment | Q33407719 | ||
| Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis | Q33689607 | ||
| EASL Clinical Practice Guidelines: management of hepatitis C virus infection | Q34168383 | ||
| Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population | Q34694441 | ||
| Clinical relevance of viral dynamics and genotypes in hepatitis B virus | Q35020824 | ||
| Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon? | Q35077408 | ||
| Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | Q35833031 | ||
| Predictors of response to therapy for chronic hepatitis C. | Q35877904 | ||
| Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study | Q36006322 | ||
| Current status of hepatitis C virus infection in Korea | Q36258735 | ||
| High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice | Q36756380 | ||
| Hepatitis C genotype 4: What we know and what we don't yet know. | Q37073708 | ||
| The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C. | Q38563358 | ||
| Current status of and strategies for hepatitis C control in South Korea | Q41808225 | ||
| Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load | Q42978648 | ||
| Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors | Q42982312 | ||
| Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients | Q43033484 | ||
| Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. | Q43040369 | ||
| Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. | Q43046858 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | virology | Q7215 |
| P304 | page(s) | 989-997 | |
| P577 | publication date | 2018-03-14 | |
| P1433 | published in | The Korean journal of internal medicine | Q26842387 |
| P1476 | title | Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C | |
| P478 | volume | 34 |
Search more.